A bright future for risk reduction in TAVR procedures using CEP devices
A hot topic of discussion at recent conferences has been the release of data from the Protected TAVR trial, which looked at Cerebral Embolic Protection (CEP) for Transcatheter Aortic Valve Replacement (TAVR). Currently, approximately 3% of patients undergoing TAVR experience a stroke during the procedure, with roughly half of those being severe or devastating strokes. […]
